Kymera Therapeutics
KYMR
#1949
Rank
NZ$17.99 B
Marketcap
NZ$210.79
Share price
-3.42%
Change (1 day)
79.22%
Change (1 year)

EPS for Kymera Therapeutics (KYMR)

EPS in 2026 (TTM): NZ-$6.34

According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$6.62. In 2025 the company made an earnings per share (EPS) of NZ-$6.73 a decrease over its 2024 EPS that were of NZ-$5.43.

EPS history for Kymera Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.34-5.7%
2025NZ-$6.7323.91%
2024NZ-$5.4317.86%
2023NZ-$4.61-12.5%
2022NZ-$5.2639.81%
2021NZ-$3.7722.84%
2020NZ-$3.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.47-62.71%๐Ÿ‡บ๐Ÿ‡ธ USA